Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,826 signal articles · 40 in last 24h · 148,777 total before filter · latest 1h ago
40last 24h
979last 7d
106● bullish (7d)
122● bearish (7d)
212publishers
AllMacro375Earnings111M&A96Regulatory9Product13Analyst7
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
2 Reasons to Like HXL and 1 to Stay Skeptical
StockStory2d agoneutral
2 Reasons to Like HXL and 1 to Stay Skeptical

While the S&P 500 is up 14% since March 2026, Hexcel (currently trading at $88.04 per share) has lagged behind, posting a return of 8.6%. This might have investors contemplating their next move.

Is Palantir's Lead Over Its Peers Already Priced In?
Trefis2d agoneutral
Is Palantir's Lead Over Its Peers Already Priced In?

Palantir Technologies (PLTR) grew revenue faster over the past twelve months than every company in its peer group, and only one company in that group earns a wider operating margin. Palantir also carries the group's highest earnings multiple. Over those same twelve months the stock returned less than the S&P 500. The operational lead is evident, but current market valuations appear to price in much of that outperformance.

Big Tech’s sudden millionaires experience growing pains settling into new wealth
Yahoo Finance Video2d agoneutralVIDEO
Big Tech’s sudden millionaires experience growing pains settling into new wealth

Morning Brief Host Julie Hyman is joined by Yahoo Finance's Jake Conley and Washington Crossing Advisors senior portfolio manager Chad Morganlander to discuss the influx of new wealth brought on by major IPOs like SpaceX (SPCX) and how these overnight millionaires are spending newfound wealth on life experiences.

2 Reasons to Like VRTX (and 1 Not So Much)
StockStory2d agoneutral
2 Reasons to Like VRTX (and 1 Not So Much)

Vertex Pharmaceuticals has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.9% to $514.18 per share while the index has gained 14%.

What's Moving Markets Today?
The Wall Street Journal2d agoneutral
What's Moving Markets Today?

Major indexes edged lower as the yield on the 10-year Treasury note pushed past 5%. Markets have had a lot to digest this week: a quarter-point interest-rate hike, fluctuating fuel prices and big tech's P(doom)--aka the probability that AI results in a existentially catastrophic outcome, according to the Silicon Valley ecosystem.

Forkast News2d agoneutral
The Asia Agent Wave – Manus, Enhans, and Huawei All Moved This Week

The global AI agent market is no longer a singular, borderless frontier. This week, three distinct developments across Asia-involving Manus, Enhans, and Huawei-demonstrate that the next phase of agentic deployment is being shaped by regional capital, sovereign infrastructure, and heavy-handed regulatory oversight. While US-based firms like Sierra and Cognition continue to command massive valuations, the […]

2 Reasons to Watch BNY and 1 to Stay Cautious
StockStory2d agoneutral
2 Reasons to Watch BNY and 1 to Stay Cautious

BNY currently trades at $153.89 and has been a dream stock for shareholders. It’s returned 210% since September 2021, nearly tripling the S&P 500’s 73.7% gain. The company has also beaten the index over the past six months as its stock price is up 34.2% thanks to its solid quarterly results.